BCLI - BRAINSTORM CELL THERAPEUTICS INC.
0.84
-0.330 -39.286%
Share volume: 819,677
Last Updated: 07-18-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$1.17
-0.33
-0.28%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 3.348 M | 5.683 M | 2.025 M | 3.571 M | 2.566 M | 1.380 M | |
| Current Assets | 1.259 M | 3.816 M | 364.000 K | 2.332 M | 1.515 M | 508.000 K | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 779.000 K | 3.469 M | 168.000 K | 1.644 M | 824.000 K | 5.000 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 622.000 K | 558.000 K | 499.000 K | 382.000 K | 331.000 K | 283.000 K | |
| Other Assets | 1.467 M | 1.309 M | 1.162 M | 857.000 K | 720.000 K | 589.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 3.348 M | 5.683 M | 2.025 M | 3.571 M | 2.566 M | 1.380 M | |
| Total liabilities | 8.898 M | 9.210 M | 8.082 M | 11.028 M | 8.623 M | 9.073 M | |
| Total current liabilities | 6.831 M | 7.691 M | 7.082 M | 10.901 M | 8.528 M | 9.023 M | |
| Accounts Payable | 4.690 M | 5.340 M | 4.603 M | 6.797 M | 5.997 M | 6.420 M | |
| Other liabilities | 2.067 M | 1.519 M | 1.000 M | 127.000 K | 95.000 K | 50.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 2.067 M | 1.519 M | 1.000 M | 127.000 K | 95.000 K | 50.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -5.550 M | -3.527 M | -6.057 M | -7.457 M | 226.346 M | -7.693 M | |
| Common stock | 212.980 M | 217.544 M | 217.722 M | 222.159 M | 226.462 M | 226.932 M | |
| Retained earnings | -218.414 M | -220.955 M | -223.663 M | -229.500 M | 0.000 | -234.509 M |